top of page

Oncology
Panel

Cancer is an increasing health challenge in India, with the number of cancer cases projected to go up from 14.6 lakh in 2022 to 15.7 lakh in 2025, according to ICMR-NCRP.

 

Advances in diagnostic technology aids in the early detection of cancer. Real-time PCR technology is a highly sensitive method not only for detection but also for characterization of minimal residual disease from samples of patients with cancer. RT-PCR shows high sensitivity and specificity for a known fusion transcript.

BCR ABL Qualitative MMM

BCR-ABL Qualitative RT-PCR Kit - Major, Minor, Micro

for specific detection of Major (M-BCR) p210, Minor (m-BCR) p190, and Micro (μ-BCR) p230 BCR-ABL transcripts

BCR-ABL Quantitative RT-PCR Kit - Major, Minor and Micro

BCR-ABL Quantitative RT-PCR Kit - Major, Minor and Micro

an IS quantitative, one-step RT-PCR for quantifying the IS ratios for BCR-ABL Major (M-BCR) p210 transcript and to determine the NCN % of Minor (m-BCR) p190, and Micro (μ-BCR) p230 BCR-ABL transcripts

BCR ABL1 Quantitative RT PCR Kit- Major

BCR-ABL1 Quantitative RT-PCR Kit - Major

an IS quantitative, one-step RT PCR for quantifying the IS ratios of BCR-ABL Major (M-BCR) p210 transcript

bottom of page